Retraction Note: BMC Complement Med Ther 15, 182 (2015)
10.1186/s12906-015-0707-3
The Editor has retracted this article. After publication, concerns were raised regarding similar western blot control images in this article and the authors’ previous publication [1]. The authors explained that the data in the two articles originated from the same experiments. Further checks by the Publisher identified the use of the SKOV6 cell line, which is reported to be contaminated with HeLa cells, making it an unsuitable model for ovarian cancer. This undermines the conclusion that Yukyung Karne could be used in the management of ovarian cancer metastasis. Due to the cell line issue, the Editor no longer has confidence in the conclusions of this article.
None of the authors agree to this retraction.
Footnotes
The online version of the original article can be found at 10.1186/s12906-015-0707-3.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
References
- 1.Choedon T, Dolma D, Mathan G, et al. Molecular insights into the anti-cancer properties of traditional tibetan medicine Yukyung Karne. BMC Complement Altern Med. 2014;14:380. doi: 10.1186/1472-6882-14-380. [DOI] [PMC free article] [PubMed] [Google Scholar] [Retracted]